BIOCON · Biocon Limited · Financials
Volume · Nov 12
350.87K
Avg daily vol (3M)
435.55K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
169.27B
+10.9%
FY2026
Net Income
3.86B
-61.9%
FY2026
Operating Cash Flow
19.94B
-50.9%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| INR | 174.15B | 169.27B | 152.62B | 147.56B | 111.74B | 81.84B | 71.06B | 63.67B | 55.14B |
| INR | 21.4B | 19.57B | 16.87B | 15.69B | 11.13B | 8.14B | 7.15B | 5.52B | 4.48B |
| INR | 8.95B | 9.9B | 8.97B | 9.74B | 4.19B | 676M | 577M | 649M | 709M |
| INR | 3.62B | 4.48B | 18.87B | — | — | — | — | — | — |
| INR | 218M | 791M | 4.57B | 2.27B | 2.54B | 2.12B | 2.22B | 3.15B | 2.12B |
| INR | 4.52B | 3.86B | 10.13B | 10.23B | 4.63B | 6.48B | 7.41B | 7.48B | 9.05B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 4.49B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.